News

A new Northwestern study shows piperacillin, an antibiotic, effectively cured mice of Lyme disease at a dose 100 times smaller than the effective dose of doxycycline, the current gold-standard treatment.

Northwestern Medicine investigators have discovered new intracellular mechanisms that help specialized immune cells adapt and respond to disease and acute inflammation, findings that may inform the development of targeted therapies for cancer and tissue injury, according to a recent study published in the Journal of Clinical Investigation.

Jonathan Chen, MD, PhD, assistant professor of Pathology in the Division of Molecular Pathology, and Waihay Wong, MD, PhD, assistant professor of Pathology, have been named recipients of the 2025 Young Physician-Scientist Award.

Just two years out from its launch, the Center for Human Immunobiology has quickly become a bustling hub for collaborative efforts to understand the molecular mechanisms of the immune system and translate discoveries into innovative cures for immune-regulated diseases. 

Harnessing the body’s B-cells to fight tumors may be a promising treatment for glioblastoma, according to a Northwestern Medicine study recently published in the Journal of Clinical Investigation.

Investigators have discovered that targeting specific mechanisms linked to lipid metabolism in immune cells within tumors may improve response to current and future cancer immunotherapies, according to a recent study published in the journal Immunity.

Northwestern Medicine investigators have shed new light on how white blood cells in the retina function during inflammation and possibly during retinal vascular diseases with inflammatory components like diabetic retinopathy, according to a study recently published in the Journal of Clinical Investigation.

First-year medical students donned their white coats for the first time and marked the official start to the academic year at Founders’ Day on August 2 at Fourth Presbyterian Church in Chicago.